Australia markets closed

Nascent Biotech, Inc. (NBIO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.09980.0000 (0.00%)
At close: 01:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.94M
Enterprise value 16.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)557.81
Enterprise value/revenue N/A
Enterprise value/EBITDA -16.41

Trading information

Stock price history

Beta (5Y monthly) -3.20
52-week change 399.60%
S&P500 52-week change 322.38%
52-week high 30.2800
52-week low 30.0323
50-day moving average 30.1241
200-day moving average 30.1309

Share statistics

Avg vol (3-month) 349.86k
Avg vol (10-day) 351.41k
Shares outstanding 5169.73M
Implied shares outstanding 6169.73M
Float 893.95M
% held by insiders 140.00%
% held by institutions 10.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-233.37%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-2.09M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)623.85k
Total cash per share (mrq)0
Total debt (mrq)125k
Total debt/equity (mrq)411.63%
Current ratio (mrq)1.05
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.22M
Levered free cash flow (ttm)-1.25M